ArticleFrontiers in molecular neuroscience2026
Coactivation of CB1 and GPR55 promotes GABA release and motor behavior at striatonigral terminals through increased dimerization induced by CB1 activation.
Article in Frontiers in molecular neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
CB1 and GPR55 receptors form heteromers in striatal neurons; however, the effects of these heteromers on GABA release at their terminals and their impact on motor behavior remain unknown. In this study, we investigate the presence of CB1-GPR55 heteromers on striatonigral neurons and their axon terminals, and also assess their impact on cAMP accumulation, GABA release, and motor behavior. Furthermore, we explore the effects of sequential receptor activation to examine the phenomenon of increased dimerization induced by receptor activation. A PLA assay combined with Substance P immunofluorescence demonstrated the presence of CB1-GPR55 heteromers in the dorsal striatum and substantia nigra of rats. The kainic acid lesion in the striatum leads to a decrease in PLA dots in both regions. Sequential activation of CB1R, followed by GPR55 activation (CB1→GPR55), increased cAMP accumulation and GABA release at the nigral terminals more compared to GPR55 alone activation. In contrast, simultaneous activation (CB1 + GPR55) or the reverse (GPR55→CB1) did not affect the stimulation effects of GPR55 on cAMP accumulation or GABA release. Additionally, CB1/GPR55 immunoprecipitation in synaptosomes revealed an increase during the sequential activation of CB1→GPR55. Treatments with PTx or ChTx did not alter the effects of CB1→GPR55 sequential activation on GABA release. Finally, intranigral injections of a CB1→GPR55 agonist induced more contralateral turns than GPR55 activation alone. These findings indicate that the sequential activation of CB1→GPR55 within CB1/GPR55 heteromers in striatonigral neurons enhances cAMP accumulation, GABA release, and motor behavior by increasing heteromerization via CB1 activation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.